RE:RE:RE:What Hunter Syndrome Could Be Worth:"no one pays even $4M for pre-clinical stage products"
Armagen received US$15 million in upfront cash and equity investments alone for Hunter's Syndrome, in addition to the other payments and royalties. What did the equity investment value Armagen at? As for what preclinical science can be worth, Moderna has been valued in the multi-billions of dollars and has yet to enter human testing for its mRNA technology.
As for being preclinical, BTI is delivering products already tested in humans such as Herceptin which is FDA approved. We already know that if we can deliver the enzymes in Lysosomal Storage Disease or Herceptin to the brain they can work based upon human evidence. BTI is using animal models validated in humans for these drugs.
Concerning Transcend it is based upon a natural solution the human body uses to transport iron. As this video says, the solution is elegant, brillient. It uses the body's own natural solution for delivery over the blood-brain barrier:
https://www.youtube.com/watch?v=RgAG6FzszdU